Syndax Pharmaceuticals is looking for a Director, Commercial Regulatory Affairs, Labeling, Advertising, and Promotion
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies.
The Role:
We are currently seeking a qualified, highly motivated, experienced individual for the position of Director, Commercial Regulatory Affairs, Labeling, Advertising, and Promotion to lead labeling activities and the review of promotional materials in commercial regulatory affairs at Syndax for the company’s 2 marketed FDA approved products in acute leukemia and chronic GVHD. The position reports to the Executive Director, Commercial Regulatory Affairs.
The Director will lead and provide strategic input and oversight of regulatory labeling activities including labeling strategy for future indications of the lead company asset. The Director will lead the Labeling Working Group (LWG) meeting to develop an optimal Target Product Label (TPL), and U.S. Product Information (USPI) strategy and EU SmPC when applicable. This role will represent RA Labeling as the functional representative across the organizational levels relevant to assigned products and/or other activities. This role may include future responsibilities for managing, overseeing, reviewing, and approving the work of more junior staff related to labeling activities. This role will help to serve regulatory strategy in managing complex labeling negotiations with regulatory health authorities for future label expansion. This role also serves the as a central point of contact and expert for global Regulatory teams in interpreting content and messaging of Company Core Data Sheets (CCDSs) and USPIs. The Director will act as a key advisor to cross-functional partners, stakeholders, and teams and lead impact assessments on major labeling issues. This role will assist with cross-functional meetings involved in the governance and decision-making of regulatory labeling with senior leadership in Labe Committee (LC) and when applicable strategic Task Forces for critical labeling workstreams. This role will be responsible for training cross-functional partners and teams on labeling processes, policies, procedures, standards, etc.
The Director will engage business partners for planning and implementation on issues pertaining to product promotion and will participate in the review and approval of promotional materials under the guidance of the Executive Director, Commercial Regulatory as assigned. This role will include regulatory review of promotional materials for 2 marketed products with opportunities to further refine regulatory review skills in complex areas.
He or she will provide the regulatory aspects for the review and approval process for product promotion materials working collaboratively with respective legal, medical and commercial colleagues. This role involves interacting with commercial, medical and legal on a regular basis. The candidate will have direct influence on the decision-making processes within the Promotional Review Committee (PRC) within the scope of the advertising and promotion of assigned marketed products and commercial compliance for Syndax.
Key Responsibilities:
Desired Experience/Education and Personal Attributes:
Location: Syndax’s corporate office is in New York, NY.
Syndax offers a total compensation and rewards package that is among the most competitive in the industry. Base pay is just one element of our package and is determined within a range based on several factors including market data, experience, qualifications, demonstrated skills, relevant education or training, travel requirements and internal equity. Our overall package also includes an equity offering, annual target bonuses, and an outstanding benefits program. The anticipated annualized salary range for this role is $225,000 - $250,000.
About Syndax:
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com/ or follow the Company on X and LinkedIn.
Syndax Pharmaceuticals is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
#LI-Remote